Page 22 - Read Online

Murray Primary circulating prostate cells

molecule. Am J Pathol 2007;171:386-95. 68. Rhim AD, Thege FI, Santana SM, Lannin TB, Saha TN, Tsai S,
51. Fidler IJ. Metastasis: quantitative analysis of distribution and fate Maggs LR, Kochman ML, Ginsberg GG, Lieb JG, Chandrasekhara V,
of tumor emboli labeled with 125 I-5-iodo-2′-deoxyuridine. J Natl Drebin JA, Ahmad N, Yang YX, Kirby BJ, Stanger BZ. Detection of
Cancer Inst 1970;45:773-82. circulating pancreas epithelial cells in patients with pancreatic cystic
52. Liotta LA, Saidel MG, Kleinerman J. The significance of lesions. Gastroenterology 2014;146:647-51.
hematogenous tumor cell clumps in the metastatic process. Cancer 69. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C,
Res 1976;36:889-94. Tibbe AG, Uhr JW, Terstappen LW. Tumor cells circulate in the peripheral
53. Carvalho FL, Simons BW, Antonarakis ES, Rasheed Z, Douglas blood of all major carcinomas but not in healthy subjects or patients with
N, Villegas D, Matsui W, Berman DM. Tumorigenic potential of nonmalignant diseases. Clin Cancer Res 2004;10:6897-904.
circulating prostate tumor cells. Oncotarget 2013;4:413-21. 70. Pantel K, Denéve E, Nocca D, Coffy A, Vendrell JP, Maudelonde T,
54. Smerage JB, Budd GT, Doyle GV, Brown M, Paoletti C, Muniz M, Riethdorf S, Alix-Panabières C. Circulating epitelial cells in patients
Miller MC, Repollet MI, Chianese DA, Connelly MC, Terstappen LW, with benign colon diseases. Clin Chem 2012;58:936-40.
Hayes DF. Monitoring apoptosis and Bcl-2 on circulating tumor cells 71. Stott SL, Hsu CH, Tsukrov DI, Yu M, Miyamoto DT, Waltman BA,
in patients with metastatic breast cancer. Mol Oncol 2013;7:680-92. Rothenberg SM, Shah AM, Smas ME, Korir GK, Floyd FP Jr, Gilman
55. Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E, AJ, Lord JB, Winokur D, Springer S, Irimia D, Nagrath S, Sequist LV,
Peeper DS. Suppression of anoikis and induction of metastasis by the Lee RJ, Isselbacher KJ, Maheswaran S, Haber DA, Toner M. Isolation
neurotrophic receptor TrkB. Nature 2004;430:1034-9. of circulating tumor cells using a microvortex generating herring
56. Steinert G, Schölch S, Niemietz T, Iwata N, García SA, Behrens B, bone-chip. Proc Natl Acad Sci U S A 2010;107:18392-7.
Voigt A, Kloor M, Benner A, Bork U, Rahbari NN, Büchler MW, 72. Chinen LT, de Carvalho FM, Rocha BM, Aguiar CM, Abdallah EA,
Stoecklein NH, Weitz J, Koch M. Immune escape and survival Campanha D, Mingues NB, de Oliveira TB, Maciel MS, Cervantes
mechanisms in circulating tumor cells of colorectal cancer. Cancer GM, Dettino AL, Soares FA, Paterlini-Bréchot P, Fanelli MF.
Res 2014;74:1694-704. Cytokeratin based CTC counting unrelated to clinical follow up. J
57. Liu Q, Liao Q, Zhao Y. Myeloid derived suppressor cells (MDSC) Thorac Dis 2013;5:593-9.
facilitate distant metastasis of malignancies by shielding circulating 73. Liu Z, Fusi A, Klopocki E, Schmittel A, Tinhofer I, Nonnenmacher A,
tumor cells (CTCs) from immune surveillance. Med Hypothesis Keilholz U. Negative enrichment by immunomagnetic-nanobeads for
2016;87:34-9. unbiased characterization of circulating tumor cells from peripheral
58. Placke T, Örgel M, Schaller M, Jung G, Rammensee HG, Kopp HG, blood of cancer patients. J Transl Med 2011;9:70.
Salih HR. Platelet derived MHC class I confers a pseudo-normal 74. Borgen E, Naume B, Nesland JM, Kvalheim G, Beiske K, Fodstad
phenotype to cancer cells that subverts the antitumor reactivity of O, Diel I, Solomayer EF, Theocharous P, Coombes RC, Smith BM,
natural killer immune cells. Cancer Res 2012;72:440-8. Wunder E, Marolleau JP, Garcia J, Pantel K. Standardization of the
59. Parkinson DR, Dracopoli N, Petty BG, Compton C, Cristofanilli immunocytochemical detection of cancer cells in BM and blood. I.
M, Deisseroth A, Hayes DF, Kapke G, Kumar P, Lee JSh, Liu MC, Establishment of objective criteria for the evaluation of immunostained
McCormack R, Mikulski S, Nagahara L, Pantel K, Pearson-White cells. Cytotherapy 1999;1:377-88.
S, Punnoose EA, Roadcap LT, Schade AE, Scher HI, Sigman CC, 75. Murray NP, Calaf GM, Badinez L, Dueñas R, Badinez O, Orellana N,
Kelloff GJ. Considerations in the development of circulating tumor Reyes E, Fuentealba C. P504S expressing circulating prostate cells as
cell technology for clinical use. J Translat Med 2012;10:138. a marker for prostate cancer. Oncol Reports 2010;24:687-92.
60. Panteleakou Z, Lembessis P. Sourla A, Pissimissis N, Polyzos A, 76. Murray NP, Miranda R, Ruiz A, Droguett E. Diagnostic yield of
Deliveliotis C, Koutsilieris M. Detection of circulating tumor cells primary circulating tumor cells in women suspected of breast cancer:
in prostate cancer patients: methodological pitfalls and clinical the BEST (Breast Early Screening Test) study. Asian Pac J Cancer
relevance. Mol Med 2009;15:101-14. Prev 2015;16:1929-34.
61. Brandt B, Junker R, Griwatz C, Heidl S, Brinkmann O, Semjonow A, 77. Zhou M, ChinnaiyanAM, Kleer CG, Lucas PC, Rubin MA. Alpha-
Assmann G, Zänker KS. Isolation of prostate-derived single cells and cell methylacyl-CoA racemase: a novel tumor marker over-expressed
clusters from human peripheral blood. Cancer Res 1996;56:4556-61. in several human cancers and their precursor lesions. Am J of Surg
62. Mu Z, Wang C, Ye Z, Austin L, Civan J, Hyslop T, Palazzo JP, Pathol 2002;26:926-31.
Jaslow R, Li B, Myers RE, Jiang J, Xing J, Yang H, Cristofanilli M. 78. Beach R, Gown AM, De Peralta-Venturina MN, Folpe AL,
Prospective assessment of the prognostic value of circulating tumor Yaziji H, Salles PG, Grignon DJ, Fanger GR, Amin MB. P504S
cells and their clusters in patients with advanced-stage breast cancer. immunohistochemical detection in 405 prostatic specimens including
Breast Cancer Res Treat 2015;154:563-71. 376 18-gauge needle biopsies. Am J Surg Pathol 2002;26:1588-96.
63. Gertler R, Rosenberg R, Fuehrer K, Dahm M, Nekarda H, Siewert JR. 79. Murray NP, Reyes E, Badinez L, Orellana N, Fuentealba C, Olivares
Detection of circulating tumor cells in blood using an optimized density R, Porcell J, Dueñas R. Circulating prostate cells found in men with
gradient centrifugation. Recent Results Cancer Res 2003;162:149-55. benign prostate disease are p504s negative: clinical implications. J
64. Rosenberg R, Gertler R, Friederichs J, Fuehrer K, Dahm M, Phelps Oncol 2013;2013:165014.
R, Thorban S, Nekarda H, Siewert JR. Comparison of two density 80. Mu Z, Wang C, Ye Z, Austin L, Civan J, Hyslop T, Palazzo JP,
gradient centrifugation systems for the enrichment of disseminated Jaslow R, Li B, Myers RE, Jiang J, Xing J, Yang H, Cristofanilli M.
tumor cells in blood. Cytometry 2002;49:150-8. Prospective assessment of the prognostic value of circulating tumor
65. Seal SH. A sieve for the isolation of cancer cells and other large cells cells and their clusters in patients with advanced-stage breast cancer.
from blood. Cancer 1964;17:637-42. Breast Cancer Res Treat 2015;154:563-71.
66. Plaks V, Koopman CD, Werb Z. Cancer. Circulating tumor cells. 81. Paoletti C, Li Y, Muniz MC, Kidwell KM, Aung K, Thomas DG, Brown
Science 2013;341:1186-8. ME, Abramson VG, Irvin WJ Jr, Lin NU, Liu MC, Nanda R, Nangia
67. De Giorgi V, Pinzani P, Salvianti F, Grazzini M, Orlando C, Lotti JR, Storniolo AM, Traina TA, Vaklavas C, Van Poznak CH, Wolff AC,
T, Pazzagli M, Massi D. Circulating benign nevus cells detected by Forero-Torres A, Hayes DF; Translational Breast Cancer Research
ISET technique: warning for melanoma molecular diagnosis. Arch Consortium (TBCRC). Significance of circulating tumor cells in
Dermatol 2010;146:1120-4. metastatic triple-negative breast cancer patients within a randomized,
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ December 16, 2016 461